Your browser doesn't support javascript.
loading
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
Boxer, Adam L; Gold, Michael; Feldman, Howard; Boeve, Bradley F; Dickinson, Susan L-J; Fillit, Howard; Ho, Carole; Paul, Robert; Pearlman, Rodney; Sutherland, Margaret; Verma, Ajay; Arneric, Stephen P; Alexander, Brian M; Dickerson, Bradford C; Dorsey, Earl Ray; Grossman, Murray; Huey, Edward D; Irizarry, Michael C; Marks, William J; Masellis, Mario; McFarland, Frances; Niehoff, Debra; Onyike, Chiadi U; Paganoni, Sabrina; Panzara, Michael A; Rockwood, Kenneth; Rohrer, Jonathan D; Rosen, Howard; Schuck, Robert N; Soares, Holly D; Tatton, Nadine.
Affiliation
  • Boxer AL; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
  • Gold M; Development Neurosciences, AbbVie, Chicago, IL, USA.
  • Feldman H; Department of Neurosciences, University of California San Diego, San Diego, CA, USA.
  • Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Dickinson SL; Association for Frontotemporal Degeneration, Radnor, PA, USA.
  • Fillit H; Alzheimer's Drug Discovery Foundation, New York, NY, USA.
  • Ho C; Denali Therapeutics, San Francisco, CA, USA.
  • Paul R; Alector, Inc., South San Francisco, CA, USA.
  • Pearlman R; The Bluefield Project, San Francisco, CA, USA.
  • Sutherland M; Chan Zuckerberg Initiative, Redwood City, CA, USA.
  • Verma A; United Neuroscience, Dublin, Ireland.
  • Arneric SP; Critical Path Institute, Tucson, AZ, USA.
  • Alexander BM; Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA.
  • Dickerson BC; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Dorsey ER; Center for Health and Technology, University of Rochester, Rochester, NY, USA.
  • Grossman M; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
  • Huey ED; Departments of Psychiatry and Neurology, Columbia University, NY, USA.
  • Irizarry MC; Formerly of Early Phase Neurosciences, Eli Lilly, Indianapolis, IN, USA.
  • Marks WJ; Clinical Neurology, Verily Life Sciences, South San Francisco, CA, USA.
  • Masellis M; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, ON, Canada.
  • McFarland F; Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada.
  • Niehoff D; McFarland Writing, Annapolis, MD, USA.
  • Onyike CU; Association for Frontotemporal Degeneration, Radnor, PA, USA.
  • Paganoni S; Department Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University, Baltimore, MD, USA.
  • Panzara MA; Healey Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
  • Rockwood K; Development, Wave Life Sciences, Boston, MA, USA.
  • Rohrer JD; Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.
  • Rosen H; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.
  • Schuck RN; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
  • Soares HD; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA.
  • Tatton N; Department of Neurology, AbbVie, Chicago, IL, USA.
Alzheimers Dement ; 16(1): 131-143, 2020 01.
Article in En | MEDLINE | ID: mdl-31668596

Full text: 1 Database: MEDLINE Main subject: Magnetic Resonance Imaging / Biomarkers / Clinical Trials as Topic / Frontotemporal Lobar Degeneration Limits: Humans Language: En Journal: Alzheimers Dement Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Magnetic Resonance Imaging / Biomarkers / Clinical Trials as Topic / Frontotemporal Lobar Degeneration Limits: Humans Language: En Journal: Alzheimers Dement Year: 2020 Type: Article Affiliation country: United States